Hoth Therapeutics , Inc. (NASDAQ:HOTH), a biopharmaceutical company, announced today that it has increased the maximum aggregate offering price of its common stock by $5 million under its existing At ...

There is near consensus by capital markets experts that the initial public offering market is open, and will remain open ...

Market insiders say entrepreneurs are losing interest in raising funds through initial public offerings (IPOs), while the prolonged absence of new company listings has further dampened investor enthus ...

Management anticipates continued growth in MDT strategies and private market offerings, supported by the launch of new funds such as the European Direct Lending III and the GPE Innovation Fund II.

Median returns three months post IPO 2024 performance (the green line in Chart 5) were much better than the last two years (purple and pink lines). Importantly, 2024 IPOs as a group have so far held ...

Obesity-drug maker Metsera Inc.’s stock jumped 47% on Friday as the biggest gainer among three initial public offerings ...

Q2 2025 Management View CEO Max Levchin emphasized the company's strong quarter, highlighting its focus on delivering sophisticated subsidized APRs, including 0% loans. He noted the successful ...

Catheter’s ability to continue development of PeriKard’s products and gain the regulatory approvals needed to bring the products to market, that the anticipated PeriKard product offering will ...